US Asset Management LLC’s Zimmer Biomet ZBH Stock Holding History

US Asset Management LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-256	Closed	-$33K	–	235
2023 Q1	$33K	Hold	256	–	–	0.03%	204
2022 Q4	$33K	Buy	+256	New	+$29.7K	0.04%	205
2022 Q2	$27K	Hold	256	–	–	0.03%	216
2022 Q1	$33K	Buy	+256	New	+$30.9K	0.03%	217
2021 Q4	–	Sell	-264	Closed	-$37K	–	240
2021 Q3	$37K	Buy	+264	New	+$38.8K	0.04%	209

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

US Asset Management LLC's ZBH Position: Q2 2023 in Review

US Asset Management LLC sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 256 shares — an estimated $33K sold.

US Asset Management LLC first reported a position in ZBH in Q3 2021 and held it in 5 quarters. The position peaked at $37K in Q3 2021. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

US Asset Management LLC reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
US Asset Management LLC sold 256 Zimmer Biomet shares in Q2 2023, an estimated $33K.
US Asset Management LLC first reported a position in Zimmer Biomet in Q3 2021 and held it in 5 quarters.
US Asset Management LLC's Zimmer Biomet position peaked at $37K in Q3 2021.
1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on US Asset Management LLC's 13F filing for Q2 2023, filed 22 Aug 2023.